Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b

doi:10.1084/jem.163.4.837

This Article

	Full Text (PDF, 1873K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Seya, T.
	Articles by Atkinson, J. P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Seya, T.
	Articles by Atkinson, J. P.


Social Bookmarking

	What's this?

ARTICLES

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b

T Seya, JR Turner and JP Atkinson

Based on preliminary evidence indicating that a cell-associated protein of U937 (a human monocyte-like cell line) possessed cofactor activity and was not the C3b/C4b receptor, we sought to further characterize this protein. A sequential four-column purification procedure was devised that includes C3(H2O) affinity chromatography to isolate in reasonable yields and purity a cell-associated protein of U937 and several other human cell lines. Based on its pattern and Mr on SDS- PAGE, acidic pI, and ligand specificity, it is identical to a recently described C3(H2O) or C3b-binding membrane glycoprotein of human PBL and cell lines; having no presently identified function, it was termed gp45- 70. After purifying this protein, we determined its functional capabilities and compared them to those of the other complement proteins with regulatory activity directed at components comprising the C3 convertases. This protein was the most efficient (50 times that of H) yet-described cofactor for the I-mediated first cleavage of C3b. It also was a cofactor for the first cleavage of C4b, but was not as efficient as C4bp. The second cleavage of C3b and C4b was not efficiently mediated. It had no ability to accelerate decay in the classical or alternative pathway C3 convertases. Based on this unique activity profile and ability to be surface labeled, we have renamed this molecule membrane cofactor protein (MCP). We suggest that this protein plays a major role in preventing autologous complement activation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Haapasalo, K., Meri, T., Jokiranta, T. S. (2009). Loa loa Microfilariae Evade Complement Attack In Vivo by Acquiring Regulatory Proteins from Host Plasma. Infect. Immun. 77: 3886-3893 [Abstract] [Full Text]
Lehtinen, M. J., Rops, A. L., Isenman, D. E., van der Vlag, J., Jokiranta, T. S. (2009). Mutations of Factor H Impair Regulation of Surface-bound C3b by Three Mechanisms in Atypical Hemolytic Uremic Syndrome. J. Biol. Chem. 284: 15650-15658 [Abstract] [Full Text]
Jacobson, A. C., Weis, J. H. (2008). Comparative Functional Evolution of Human and Mouse CR1 and CR2. J. Immunol. 181: 2953-2959 [Full Text]
Fang, C. J., Fremeaux-Bacchi, V., Liszewski, M. K., Pianetti, G., Noris, M., Goodship, T. H. J., Atkinson, J. P. (2008). Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111: 624-632 [Abstract] [Full Text]
Hakulinen, J., Keski-Oja, J. (2006). ADAM10-mediated Release of Complement Membrane Cofactor Protein during Apoptosis of Epithelial Cells. J. Biol. Chem. 281: 21369-21376 [Abstract] [Full Text]
Krey, T., Himmelreich, A., Heimann, M., Menge, C., Thiel, H.-J., Maurer, K., Rumenapf, T. (2006). Function of Bovine CD46 as a Cellular Receptor for Bovine Viral Diarrhea Virus Is Determined by Complement Control Protein 1.. J. Virol. 80: 3912-3922 [Abstract] [Full Text]
Gaggar, A., Shayakhmetov, D. M., Liszewski, M. K., Atkinson, J. P., Lieber, A. (2005). Localization of Regions in CD46 That Interact with Adenovirus. J. Virol. 79: 7503-7513 [Abstract] [Full Text]
Kirchner, M., Heuer, D., Meyer, T. F. (2005). CD46-Independent Binding of Neisserial Type IV Pili and the Major Pilus Adhesin, PilC, to Human Epithelial Cells. Infect. Immun. 73: 3072-3082 [Abstract] [Full Text]
Funami, K., Matsumoto, M., Oshiumi, H., Akazawa, T., Yamamoto, A., Seya, T. (2004). The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling. Int Immunol 16: 1143-1154 [Abstract] [Full Text]
Gelderman, K A, Zijlmans, H J M A A, Vonk, M J, Gorter, A (2004). CD55 expression patterns on intestinal neuronal tissue are divergent from the brain. Gut 53: 507-513 [Abstract] [Full Text]
Lin, F., Spencer, D., Hatala, D. A., Levine, A. D., Medof, M. E. (2004). Decay-Accelerating Factor Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Colitis: Role for Complement in Inflammatory Bowel Disease. J. Immunol. 172: 3836-3841 [Abstract] [Full Text]
Maurer, K., Krey, T., Moennig, V., Thiel, H.-J., Rumenapf, T. (2004). CD46 Is a Cellular Receptor for Bovine Viral Diarrhea Virus. J. Virol. 78: 1792-1799 [Abstract] [Full Text]
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Muslumanogglu, M. H., Kavukcu, S., Filler, G., Pirson, Y., Wen, L. S., Atkinson, J. P., Goodship, T. H. J. (2003). Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. USA 100: 12966-12971 [Abstract] [Full Text]
Barilla-LaBarca, M. L., Liszewski, M. K., Lambris, J. D., Hourcade, D., Atkinson, J. P. (2002). Role of Membrane Cofactor Protein (CD46) in Regulation of C4b and C3b Deposited on Cells. J. Immunol. 168: 6298-6304 [Abstract] [Full Text]
Mori, Y., Seya, T., Huang, H. L., Akkapaiboon, P., Dhepakson, P., Yamanishi, K. (2002). Human Herpesvirus 6 Variant A but Not Variant B Induces Fusion from Without in a Variety of Human Cells through a Human Herpesvirus 6 Entry Receptor, CD46. J. Virol. 76: 6750-6761 [Abstract] [Full Text]
Miyagawa, S., Murakami, H., Takahagi, Y., Nakai, R., Yamada, M., Murase, A., Koyota, S., Koma, M., Matsunami, K., Fukuta, D., Fujimura, T., Shigehisa, T., Okabe, M., Nagashima, H., Shirakura, R., Taniguchi, N. (2001). Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig. J. Biol. Chem. 276: 39310-39319 [Abstract] [Full Text]
Weng, W.-K., Levy, R. (2001). Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma. Blood 98: 1352-1357 [Abstract] [Full Text]
Tobiason, D. M., Seifert, H. S. (2001). Inverse relationship between pilus-mediated gonococcal adherence and surface expression of the pilus receptor, CD46. Microbiology 147: 2333-2340 [Abstract] [Full Text]
Holmberg, M. T., Blom, A. M., Meri, S. (2001). Regulation of Complement Classical Pathway by Association of C4b-Binding Protein to the Surfaces of SK-OV-3 and Caov-3 Ovarian Adenocarcinoma Cells. J. Immunol. 167: 935-939 [Abstract] [Full Text]
Kurita-Taniguchi, M., Fukui, A., Hazeki, K., Hirano, A., Tsuji, S., Matsumoto, M., Watanabe, M., Ueda, S., Seya, T. (2000). Functional Modulation of Human Macrophages Through CD46 (Measles Virus Receptor): Production of IL-12 p40 and Nitric Oxide in Association with Recruitment of Protein-Tyrosine Phosphatase SHP-1 to CD46. J. Immunol. 165: 5143-5152 [Abstract] [Full Text]
Brodbeck, W. G., Mold, C., Atkinson, J. P., Medof, M. E. (2000). Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack. J. Immunol. 165: 3999-4006 [Abstract] [Full Text]
Junnikkala, S., Jokiranta, T. S., Friese, M. A., Jarva, H., Zipfel, P. F., Meri, S. (2000). Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 1. J. Immunol. 164: 6075-6081 [Abstract] [Full Text]
Manchester, M., Eto, D. S., Valsamakis, A., Liton, P. B., Fernandez-Muñoz, R., Rota, P. A., Bellini, W. J., Forthal, D. N., Oldstone, M. B. A. (2000). Clinical Isolates of Measles Virus Use CD46 as a Cellular Receptor. J. Virol. 74: 3967-3974 [Abstract] [Full Text]
Christiansen, D., Loveland, B., Kyriakou, P., Lanteri, M., Escoffier, C., Gerlier, D. (2000). Interaction of CD46 with measles virus: accessory role of CD46 short consensus repeat IV. J. Gen. Virol. 81: 911-917 [Abstract] [Full Text]
Varsano, S., Rashkovsky, L., Shapiro, H., Radnay, J. (1998). Cytokines Modulate Expression of Cell-Membrane Complement Inhibitory Proteins in Human Lung Cancer Cell Lines. Am. J. Respir. Cell Mol. Bio. 19: 522-529 [Abstract] [Full Text]
Hakulinen, J., Meri, S. (1998). Complement-Mediated Killing of Microtumors in Vitro. Am. J. Pathol. 153: 845-855 [Abstract] [Full Text]
Tanemura, M., Miyagawa, S., Koyota, S., Koma, M., Matsuda, H., Tsuji, S., Shirakura, R., Taniguchi, N. (1998). Reduction of the Major Swine Xenoantigen, the alpha -Galactosyl Epitope by Transfection of the alpha 2,3-Sialyltransferase Gene. J. Biol. Chem. 273: 16421-16425 [Abstract] [Full Text]
Makrides, S. C. (1998). Therapeutic Inhibition of the Complement System. Pharmacol. Rev. 50: 59-88 [Abstract] [Full Text]
Kraus, D., Medof, M. E., Mold, C. (1998). Complementary Recognition of Alternative Pathway Activators by Decay-Accelerating Factor and Factor H. Infect. Immun. 66: 399-405 [Abstract] [Full Text]
Gorelick, A., Oglesby, T., Rashbaum, W., Atkinson, J., Buyon, J.P. (1995). Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heart. Lupus 4: 293-296 [Abstract]
Iwata, K., Seya, T., Yanagi, Y., Pesando, J. M., Johnson, P. M., Okabe, M., Ueda, S., Ariga, H., Nagasawa, S. (1995). Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46. J. Biol. Chem. 270: 15148-15152 [Abstract] [Full Text]
Weisman, H., Bartow, T, Leppo, M., Marsh, H. Jr, Carson, G., Concino, M., Boyle, M., Roux, K., Weisfeldt, M., Fearon, D. (1990). Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151 [Abstract]